Abstract
Introduction
Genetic discoveries are validated through the meta-analysis of genome-wide association scans in large international consortia. Because environmental variables may interact with genetic factors, investigation of differing genetic effects for distinct levels of an environmental exposure in these large consortia may yield additional susceptibility loci undetected by main effects analysis. We describe a method of joint meta-analysis of SNP and SNP by Environment (SNP×E) regression coefficients for use in gene-environment interaction studies.
Methods
In testing SNP×E interactions, one approach uses a two degree of freedom test to identify genetic variants that influence the trait of interest. This approach detects both main and interaction effects between the trait and the SNP. We propose a method to jointly meta-analyze the SNP and SNP×E coefficients using multivariate generalized least squares. This approach provides confidence intervals of the two estimates, a joint significance test for SNP and SNP×E terms, and a test of homogeneity across samples.
Results
We present a simulation study comparing this method to four other methods of meta-analysis and demonstrate that the joint meta-analysis performs better than the others when both main and interaction effects are present. Additionally, we implemented our methods in a meta-analysis of the association between SNPs from the type 2 diabetes-associated gene PPARG and log-transformed fasting insulin levels and interaction by body mass index in a combined sample of 19,466 individuals from 5 cohorts.
Keywords: 2 degree of freedom meta-analysis, joint meta-analysis, PPARG, Gene-environment interaction meta-analysis
Introduction
Genome-wide association studies have facilitated discovery of associations between genetic variants and complex phenotypes. After discovery and replication of the strongest association signals, weaker associations are discoverable only with the increased power of larger samples [McCarthy 2008]. Therefore, individual research groups have formed consortia and meta-analyzed their GWAS of complex diseases to find such signals [Ioannidis 2007, Lindgren 2009, Prokopenko 2009, Psaty 2009]. For commonly used analyses, this approach is as efficient as combining individual participant data [Lin and Zeng 2010]. However, the SNP associations identified by these consortia explain little heritability in the quantitative traits being studied. Many quantitative traits are influenced by environmental factors, which may interact with the genetic loci being tested. As a way to incorporate environmental factors, identify other genetic contributors to the trait of interest, explain the remaining heritability, and to further characterize the genetic architecture of the trait, we now wish to look beyond SNP main effect associations to SNP-environment interaction associations.
In this paper, we propose a method to jointly meta-analyze the beta coefficients for a SNP’s main effect and its interaction with an environment variable (SNP×E). This method provides meta-analytic estimates of these coefficients, as well as a joint test of significance and a test of heterogeneity. We present a simulation study to compare the joint meta-analysis to four other meta-analytic methods for detecting SNP associations in quantitative traits. Other methods have been proposed in the context of phenotypes tested in case-control designs [Murcray 2008, Chatterjee 2008]; here we focus on a quantitative trait as the outcome.
As an example illustrating our method, the Meta-Analysis of Glycemic and Insulin-related traits Consortium (MAGIC) has recently published the discovery of 16 novel loci associated with fasting glucose but only 2 novel loci associated with fasting insulin [Dupuis 2010]. The low number of SNPs associated with insulin resistance measures, as compared to those associated with insulin secretion indices, remains an intriguing empiric observation in the field. As an illustration, the MAGIC meta-analysis of 21 studies contributing up to 38,238 individuals to the discovery sample failed to detect associations between log-transformed fasting insulin and SNPs near PPARG, a known type-2 diabetes gene [Altshuler 2000]. Fasting insulin, a surrogate indicator of insulin resistance, is highly associated with body mass index (BMI), and it has been suggested that BMI interacts with the PPARG locus in influencing type 2 diabetes risk [Florez 2007, Ludovico 2007, Tonjes 2006]. Consequently, we explored methods for identifying main effect of SNPs in PPARG on levels of log(fasting insulin), and their interactions with BMI, in a meta-analysis of five cohorts comprising 19,466 individuals.
Methods
For all strategies we assume that association results are gathered from k studies where N SNPs are genotyped and the trait Y and environmental factor E are also measured. From these studies, summary statistics are available from single-SNP regressions assessing the association between Y and each SNP. Two regressions will be considered: the main effects regression, in which the association between the SNP and Y is tested while adjusting for E, and the interaction regression with both SNP and SNP×E regression terms.
Main Effects Regression Model
The mean model used in linear regression for main effects is
Here, i is the study index and the superscript M indicates coefficients pertinent to main effects. The environmental variable E can be dichotomous or continuous. Typically, the SNP will be coded as the number of a specific allele, e.g. 0, 1, or 2 minor alleles. Additional covariates may be included in this model, such as age and sex.
Interaction Regression Model
A mean model used in linear regression for interaction effects is
where the superscript I indicates coefficients pertinent to interactions. Statistical interaction is assessed by testing the null hypothesis .
Joint Meta-Analysis of SNP and SNP×E (JMA)
We propose to apply the method of Becker and Wu [2007] to simultaneously summarize the SNP and SNP×E beta coefficients from fitted interaction models. This method provides a joint test of significance of the estimates and a test of homogeneity of the regression estimates across the k studies. The benefit of the joint meta-analysis is two-fold: first, it can act as a screening tool to find SNPs which may have significant main or interaction effects and second, SNPs may only show significant associations when interaction is considered.
For each study, linear unbiased estimators and are computed. We assume the are asymptotically normally distributed with mean β and variance Σ. The purpose of this method is to estimate β and Σ.
A vector, b, is formed with the from each cohort. This vector has block-diagonal covariance under the assumption of independence among cohorts:
Since each slope vector estimates β, we can rewrite the vector b as
where e follows a multivariate normal distribution with means 0 and covariance Σ̂.
The estimate of β and its covariance are obtained from generalized least squares, accounting for the unequal variances contributed to the estimate from studies of different sizes:
Confidence intervals of the beta estimates can be obtained with where is the pth element of β̂ and Cpp is the pth diagonal element of Cov(β̂). Additionally, β̂ and Cov(β̂) can be used to calculate a joint confidence region of and .
A Wald statistic TJMA = β̂T Cov(β̂)−1 β̂ follows a two degree of freedom chi-square distribution under the null hypothesis that β = 0 and can be used to test the joint significance of and .
A test of homogeneity of regression coefficients, analogous to the Cochran’s Q-test [Cochran 1954, Higgins 2002], can be performed using the statistic Q = (b−Wβ̂)T Σ−1 (b−Wβ̂). Under the null hypothesis that for all i, the test statistic Q = 0.
The summary beta estimates obtained from the joint meta-analysis are used for the interpretation of the SNP effect for varying levels of the environmental variable. Gathering terms from the model, , the effect of the SNP can be written:
with corresponding standard error:
Simulation Study
We designed a simulation study to compare the joint meta-analysis (JMA) strategy to four other meta-analytic methods. The first two produce meta-analyzed summaries of a single term: in the main effects meta-analysis, we summarize the estimate of the SNP term from the main effects regression model and in the interaction meta-analysis, we summarize the estimate of the interaction term from the interaction regression model. The third method, screening by main effects, restricts the interaction test to the subset of SNPs with main effects p-values lower than a pre-specified threshold αM. Finally, the fourth method, the meta-analysis of the 2 degree of freedom test, jointly tests the SNP and SNP×E regression coefficients.
Meta-Analysis of SNP Main Effects
In the study of SNP associations, the main effect of a SNP will often be assessed prior to performing interaction regressions. The estimates can be summarized across the k studies using an inverse-variance weighted meta-analysis [Petitti 2000]. We define , where , as a weighted average of the from each study. Here, the weights are inversely proportional to the estimated variance of the beta estimates.
The estimated standard error of is:
To test the null hypothesis that is equal to zero, the test statistic, TMAIN, can be constructed:
and compared to a one degree of freedom chi-square distribution.
Meta-Analysis of Interaction Effects
The simplest approach to detect possible interaction effects is to summarize the from the k studies. This method identifies SNPs with significant interaction effects regardless of whether or not there is a main effect of the SNP. We perform the same meta-analysis as described above with the obtaining: with and the estimated standard error:
The test statistic can be compared it to a one degree of freedom chi-square distribution to test if is equal to zero.
Screening by Main Effects
One strategy for detecting SNP × E interactions when many SNPs are being tested is to assess interaction in the subset of SNPs with significant main effects [Kooperberg 2008]. Here, we perform the meta-analysis of the main effects and carry out the meta-analysis of the interaction term among those SNPs with a main effects p-value less than a pre-specified threshold αM. This limits the number of interaction tests performed, and therefore permits the use of a less stringent α-level correction. This approach has the theoretical advantage of increasing power under the assumption that the SNPs with strong interaction effects will also have marginal effects which pass the screening step. Two values of αM will be considered: 0.01 and 0.05.
To control the type I error rate, a critical assumption is that the tests at the first stage are independent of the tests at the second stage. A proof of this appears in Kooperberg [2008]. The type I error rate of α of all N SNPs is preserved by allowing NM = αM×N SNPs to pass to the second stage. The number of null SNPs reaching statistical significance at the second stage, with significance threshold of α/NM, is then NM×α/NM=N×α.
Meta-analysis of 2 Degree of Freedom Test
Kraft et al. [2007] proposed a 2 degree of freedom (2 df) test of main and interaction effects in the context of genome-wide association studies (GWAS) which detects SNPs with main effects and SNPs with heterogeneity in genetic effects across different levels of the environmental variable.
Within each study, the 2 df test statistic can be constructed: , where and . This statistic is compared to a 2 df chi-square distribution to test if both and .
The p-value of this test, pi, can then be meta-analyzed using Fisher’s method [Hedges and Olkin 1985], which provides a summarized chi-square statistic with 2k degrees of freedom:
Although this method meta-analyzes a joint test of the SNP and SNP×E beta coefficients, summary estimates of the SNP and SNP×E beta coefficients are not produced. Joint summary estimates are desirable in order to interpret the association between the SNP and the outcome in the possible presence of interaction between the SNP and E. Moreover, Fisher’s method does not take the direction of the beta coefficients into consideration.
Simulated Data
We simulated data from 5 studies with 1,000 participants each. The simulated data included a continuous environmental variable, E, a SNP with minor allele frequency of 0.30 and a quantitative trait, Y, whose mean value is a function of E and the SNP. The effect of the SNP was additive so that the mean value of Y is higher for those with more copies of the minor allele. The continuous environmental variable, E, explained 10% of the variation in Y, while the main effect of the SNP explained between 0% and 1% of the variation in Y and the interaction between E and the SNP explained between 0% and 1% of the variation in Y. In addition to the SNP associated with Y, 999 non-associated SNPs with minor allele frequencies uniformly between 0.05 and 0.5 were generated. A total of 15 scenarios were considered, with 1,000 simulations each.
In the context of multiple independent tests, a standard α-level correction can be used to determine statistical significance. If N denotes the number of SNPs tested, a Bonferroni correction of α/N can be used to define the significance threshold for an overall type I error rate of α. This controls the family-wise error rate, defined as the probability of having one or more false positive associations in each simulation, at nominal level α. For the screening method, a threshold αM must be defined. For these simulations, we set αM to 0.01 and 0.05, which translates to carrying forward 10 or 50 null SNPs to the second stage. If NM denotes the number of SNPs passing the first stage, a Bonferroni correction of α/NM can be used to define statistical significance at the second stage.
Type I Error and Power
The empirical type I error rate of each method was assessed by first observing the proportion of significant null SNPs within each simulation, using a corrected significance threshold of 0.01/999=1.001×10−5 for each set of 999 null SNPs. These proportions are averaged across all simulations. The theoretical type I error rate for each simulation is 0.01. The power of each method was determined by observing the proportion of simulations in which the associated SNP was statistically significant.
Results
Type I Error
The comparison of the empirical type I error rates in 15,000 simulations is displayed in Figure 1a. The theoretical error rate is 0.01, as each of the simulations had 999 null SNPs with a Bonferroni corrected significance level of 0.01/999=1.001×10−5. The empirical type I error rate of all 14,985,000 null SNPs and the breakdown of empirical type I error rates by minor allele frequency category are displayed in Figures 1b and 1c, respectively. These rates are reported on the SNP level, where the theoretical type I error rate is 1.001×10−5. All five methods had an empirical type I error rate with 95% confidence intervals overlapping the theoretical type I error rate indicated by a horizontal line, except the joint meta-analysis in the 0.20–0.25 minor allele frequency category, which had a slightly inflated empirical type I error rate.
Figure 1.
(A) Empirical type I error rate in 15,000 simulations of 999 null SNPs, empirical type I error rates for (B) 14,985,000 null SNPs and (C) 14,985,000 null SNPs broken into minor allele frequency categories. A horizontal line is drawn at the theoretical type I error rate in each plot.
Power
The five methods described here have different null hypotheses, resulting in differences in power when the effects of the SNP and the SNP×E terms are varied. The meta-analysis of the main effect tests the null hypothesis that , and the meta-analysis of the interaction effect tests the null hypothesis that . The screening approach tests the null hypothesis that for SNPs whose main effect meta-analysis p-value is less than αM. Finally, both the meta-analysis of the 2 df test and the joint meta-analysis (JMA) test the null hypothesis that and , although the meta-analytic methods differ.
A comparison of the power of the five methods is presented in Figure 2. When there is no interaction effect, the main effects meta-analysis, the meta-analysis of the 2 df test and the joint meta-analysis can be compared in terms of power, as these methods test the main effect of the SNP. Figure 2a describes the scenario where the percent variance in Y explained by the SNP is increased from 0% to 1% and the percent of variances of Y explained by SNP×E is 0%. The meta-analysis of the main effect has the highest power, with the joint meta-analysis having slightly less power.
Figure 2.
Power of the five methods of meta-analysis compared in the simulation study. Both the percent of the variance in the outcome explained by the SNP and the SNP×E terms vary between 0% and 1%.
When there is an interaction effect, the interaction meta-analysis and the screening approach can be added to the power comparison. Figures 2b and 2c show scenarios where the percent of variance of Y explained by SNP×E is 0.5% and 1%, respectively. In these situations, the joint meta-analysis has the highest power, except in the situation where there is no main effect (i.e. the percent variance explained by the SNP is zero), in which case the meta-analysis of the interaction alone has the highest power. When αM was set to 0.05, a more generous screening threshold, power for the screening method was decreased (data not shown) as more SNPs passed the screening and the significance threshold for the interaction analysis was lowered.
Implementation in a large genetic consortium
The missense P12A variant within the PPARG gene has been found to be associated with type 2 diabetes [Altshuler 2000], a phenotype related to insulin resistance and impaired beta-cell function. PPARG encodes the peroxisome proliferator activated receptor γ2, a transcription factor involved in adipocyte differentiation and the target of thiazolidinedione medications. It is believed that the risk allele at PPARG P12A increases risk of type 2 diabetes by reducing insulin sensitivity. The covariate Body Mass Index (BMI) is strongly associated with type 2 diabetes; individuals with higher BMI are at higher risk of the disease, and BMI may modify the risk conferred by the PPARG P12A variant [Florez 2007, Ludovico 2007, Tonjes 2006]. We assessed the association of 60 tagSNPs within 1,000 kb of PPARG with the diabetes-related quantitative trait of fasting insulin levels (as a surrogate of insulin resistance) in 5 cohorts, with sample sizes ranging between 561 and 8,367 non-diabetic participants, resulting in a sample size of 19,466 individuals. The cohorts, described in Table 1, are: the Framingham Heart Study [Meigs 1998] (FHS), the Family Heart Study [Higgins 1996, Coon 2004] (FamHS), the Cardiovascular Heart Study [Fried 1991, Cushman 1995, Psaty 2009] (CHS), the Atherosclerosis Risk in Communities Study [ARIC 1989] (ARIC) and the Dynamics of Health, Aging and Body Composition Study [Simonsick 2001] (Health ABC). The outcome trait, fasting insulin, was naturally log-transformed in order to reduce the skewness of its distribution.
Table 1.
Cohorts participating in the meta-analysis of the association between log(fasting insulin) and SNPs in the PParG gene with possible interaction with BMI.
| Cohort | Sample Size | Age Mean (SD) |
% Female | Body Mass Index Mean (SD) |
Fasting Insulin (pmol/l) Mean (SD) |
|---|---|---|---|---|---|
| CHS | 2,854 | 72.3 (5.4) | 57% | 26.0 (4.3) | 93.9 (49.1) |
| ARIC | 8,367 | 54.1 (5.7) | 54% | 26.7 (4.6) | 72.1 (53.9) |
| FamHS | 561 | 53.4 (11.9) | 47% | 27.7 (5.1) | 69.1 (43.8) |
| FHS | 6,023 | 46.2 (11.6) | 54% | 27.0 (5.0) | 29.9 (16.5) |
| Health ABC | 1,661 | 73.8 (2.8) | 47% | 26.6 (4.1) | 57.0 (40.6) |
|
| |||||
| Total | 19,466 | ||||
The −log10(p-values) of the meta-analysis of each of the 60 tagSNPs within 1000 kb of the PPARG gene are presented in Figure 3. The beta estimates and p-values for SNPs reaching statistical significance are listed in Table 2 for all methods except the screening approach. The significance threshold was α/N=0.01/60=1.67×10−4. We did not detect significant heterogeneity in the regression slopes among the five samples (p>0.01). Significant associations were seen with both the meta-analysis of the 2 df test and the joint meta-analysis. The most significant SNP, rs1801282 (PPARG P12A), had a p-value of 1.15×10−6 with the meta-analysis of the 2 df test and 8.29×10−9 with the joint meta-analysis. Neither the main effects meta-analysis nor the interaction meta-analysis produced tests with p-values less than the corrected significance threshold of 0.01/60=0.000167. For the screening approach, even though the main effects meta-analysis would have allowed the SNP to pass to the second stage with a p-value below αM = 0.01, the p-value of the interaction meta-analysis would not have been below the corrected p-value threshold of α/NM.
Figure 3.
Single SNP associations of SNPs in the PPARG gene with log(fasting insulin) in a meta-analysis of 5 studies of 19,466 non-diabetic individuals, after taking into account a putative interaction with BMI. The PPARG P12A SNP is indicated by a double-diamond and annotated with the p-value from the joint meta-analysis. The shading represents SNPs with R2 greater than 0.2 with P12A.
Table 2.
Results of meta-analysis of 3 SNPs from the PPARG gene attaining statistical significance of p < 0.01/60=0.000167 with the meta-analytic methods assessing the association of the SNP and/or the SNP×BMI regression coefficients from the main effect and interaction regression models.
| SNP | Main Effects Meta-Analysis | Interaction Meta-Analysis | Meta-Analysis of the 2 df Test | Joint Meta-Analysis | Test of Homogeneity | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| p | p | T2df (8 df) | p | TJMA (2 df) | p | p (8 df) | ||||||||
| rs1801282 | 0.0293 | 0.001 | 0.0013 | 0.44 | 46.52 | 1.15×10−6 | 0.0009 | 0.0016 | 37.22 | 8.3×10−9 | 0.317 | |||
| rs2067819 | −0.0205 | 0.005 | 0.0002 | 0.86 | 37.34 | 4.94×10−5 | −0.0237 | −0.0002 | 24.37 | 5.1×10−6 | 0.113 | |||
| rs2120825 | 0.0216 | 0.050 | 0.0005 | 0.80 | 27.33 | 2.31×10−3 | 0.0232 | 0.0006 | 22.2 | 1.5×10−5 | 0.743 | |||
The effect of the SNP rs1801282 (PPARG P12A) on log(Insulin) for BMI values of 25, 30 and 35 are displayed in Table 3. For a BMI of 25, the effect of the risk allele of rs1801282 on log(Insulin) is 0.041 (se = 0.0073), while for a BMI of 35, the effect is 0.057 (se = 0.016), demonstrating the synergistic effect of BMI on the association between PPARG P12A and log(Insulin).
Table 3.
The effect of rs1801282 (PPARG P12A) on log(fasting insulin) for three values of BMI from the joint meta-analysis.
| BMI | Effect | SE(Effect) |
|---|---|---|
| 25 | 0.041 | 0.0073 |
| 30 | 0.049 | 0.0094 |
| 35 | 0.057 | 0.0160 |
Discussion
We have shown that the joint meta-analysis (JMA) has higher power than the other methods when both main and interaction effects are present. Most of the difference in power between the methods can be attributed to the different hypotheses and to the different degrees of freedom in the tests. The main effects meta-analysis and the interaction meta-analysis have one degree of freedom, the meta-analysis of the 2 df test has 2k degrees of freedom and the JMA has 2 degrees of freedom. As demonstrated in Figure 2a, when comparing the ability of the three methods to detect the main effect in the absence of interaction, the main effects meta-analysis has the highest power, followed closely by the JMA. The meta-analysis of the 2 df test has 10 degrees of freedom, resulting in lower power than the other two methods.
The joint meta-analysis strategy simultaneously tests and estimates the SNP and SNP×E beta coefficients of an interaction regression model. This method accounts for the covariance between the SNP beta estimate and the SNP×E beta estimate. A joint test of significance is available, testing the null hypothesis that both the SNP beta and SNP×E beta are equal to zero. A confidence region of the beta estimates can be constructed using the covariance matrix of the meta-analyzed beta estimates. Finally, we provide a test of heterogeneity of the beta estimates. The meta-analyzed beta coefficients and the joint test fully characterize the association between the SNP and the outcome, allowing for a possible interaction between the SNP and the environmental variable. We have confirmed that PPARG P12A interacts with BMI in increasing insulin resistance, a phenomenon which may be extended to other putative insulin resistance loci.
The joint meta-analysis method has been implemented in METAL available from http://www.sph.umich.edu/csg/abecasis/Metal. Individual studies can obtain the required beta and covariance estimates for interaction regression models using QUICKTEST version 0.95 (http://toby.freeshell.org/software/quicktest/) and ProbABEL version 0.1–3 (http://mga.bionet.nsc.ru/yurii/ABEL/) [Aulchenko 2007].
We hope that the use of this method in appropriately sized consortia with relevant environmental variables will lead to both the identification of novel associations with complex quantitative traits and a more refined characterization of existing signals. When an environmental variable is known or suspected to contribute to the expression of complex quantitative traits and phenotypes, a greater proportion of the heritability of complex traits may be explained by accounting for the joint effects of the SNP and the SNP-environment interaction.
Acknowledgments
The authors would like to acknowledge Han Chen for his programming support in adding the Joint Meta-Analysis method to METAL as well as his work modifying QUICKTEST and ProbABEL to produce the statistics required by the Joint Meta-Analysis.
FHS
This research was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung and Blood Institute’s Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Also supported by National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK078616 to Drs. Meigs, Dupuis and Florez, NIDDK K24 DK080140 to Dr. Meigs, and NIDDK Research Career Award K23 DK65978, a Massachusetts General Hospital Physician Scientist Development Award and a Doris Duke Charitable Foundation Clinical Scientist Development Award to Dr. Florez.
Health ABC
The Health ABC Study research reported in this article was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. Reserach was also supported in part by the Intramural Research Program of the NIH, National Institute on Aging. The genome-wide association study was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences, and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C.
ARIC
The Atherosclerosis Risk in Communities Study (ARIC) is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contributions.
CHS
The CHS research reported in this article was supported by contract numbers N01-HC- 85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00069 to the Cedars Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center.
FamHS
The Family Heart Study (FamHS) work was supported in part by NIH grants 5R01 HL08770003, 5R01 HL08821502 (Michael A. Province) from NHLBI, and 5R01 DK07568102, 5R01 DK06833603 from NIDDK (Ingrid B. Borecki).
References
- The atherosclerosis risk in communities (ARIC) study: Design and objectives the ARIC investigators. Am J Epidemiol. 1989 Apr;129(4):687–702. [PubMed] [Google Scholar]
- Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000 Sep;26(1):76–80. doi: 10.1038/79216. [DOI] [PubMed] [Google Scholar]
- Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: An R library for genome-wide association analysis. Bioinformatics. 2007 May 15;23(10):1294–6. doi: 10.1093/bioinformatics/btm108. [DOI] [PubMed] [Google Scholar]
- Becker BJ, Wu MJ. The synthesis of regression slopes in meta-analysis. Statistical Science. 2007;22(3):414–29. [Google Scholar]
- Chatterjee N, Wacholder S. Invited commentary: Efficient testing of gene-environment interaction. Am J Epidemiol. 2009 Jan 15;169(2):231, 3. doi: 10.1093/aje/kwn352. discussion 234–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29. [Google Scholar]
- Coon H, Singh N, Dunn D, Eckfeldt JH, Province MA, Hopkins PN, et al. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI family heart study. Atherosclerosis. 2004 Jun;174(2):357–62. doi: 10.1016/j.atherosclerosis.2004.02.004. [DOI] [PubMed] [Google Scholar]
- Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the cardiovascular health study. Clin Chem. 1995 Feb;41(2):264–70. [PubMed] [Google Scholar]
- Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105–16. doi: 10.1038/ng.520. 02//print. Available from: http://dx.doi.org/10.1038/ng.520. [DOI] [PMC free article] [PubMed]
- Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, et al. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone J Clin Endocrinol Metab. 2007 Apr;92(4):1502–9. doi: 10.1210/jc.2006-2275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, et al. The cardiovascular health study: Design and rationale. Ann Epidemiol. 1991 Feb;1(3):263–76. doi: 10.1016/1047-2797(91)90005-w. [DOI] [PubMed] [Google Scholar]
- Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. San Diago, CA: Academic Press, Inc; 1985. The inverse chi-square method; pp. 37–9. [Google Scholar]
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539–58. doi: 10.1002/sim.1186. [DOI] [PubMed] [Google Scholar]
- Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, et al. NHLBI family heart study: Objectives and design. Am J Epidemiol. 1996 Jun 15;143(12):1219–28. doi: 10.1093/oxfordjournals.aje.a008709. [DOI] [PubMed] [Google Scholar]
- Ioannidis JP, Patsopoulos NA, Evangelou E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS One. 2007 Sep 5;2(9):e841. doi: 10.1371/journal.pone.0000841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kooperberg C, Leblanc M. Increasing the power of identifying gene x gene interactions in genome-wide association studies. Genet Epidemiol. 2008 Apr;32(3):255–63. doi: 10.1002/gepi.20300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ. Exploiting gene-environment interaction to detect genetic associations. Hum Hered. 2007;63(2):111–9. doi: 10.1159/000099183. [DOI] [PubMed] [Google Scholar]
- Lin DY, Zeng D. Meta-analysis of genome-wide association studies: No efficiency gain in using individual participant data. Genet Epidemiol. 2010 Jan;34(1):60–6. doi: 10.1002/gepi.20435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lindgren CM, Heid IM, Randall JC, Lamina C, Steinthorsdottir V, Qi L, et al. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet. 2009 Jun;5(6):e1000508. doi: 10.1371/journal.pgen.1000508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ludovico O, Pellegrini F, Di Paola R, Minenna A, Mastroianno S, Cardellini M, et al. Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk. Obesity (Silver Spring) 2007 May;15(5):1076–81. doi: 10.1038/oby.2007.617. [DOI] [PubMed] [Google Scholar]
- McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, et al. Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet. 2008 May;9(5):356–69. doi: 10.1038/nrg2344. [DOI] [PubMed] [Google Scholar]
- Meigs JB, Nathan DM, Wilson PW, Cupples LA, Singer DE. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. the framingham offspring study. Ann Intern Med. 1998 Apr 1;128(7):524–33. doi: 10.7326/0003-4819-128-7-199804010-00002. [DOI] [PubMed] [Google Scholar]
- Murcray CE, Lewinger JP, Gauderman WJ. Gene-environment interaction in genome-wide association studies Am J Epidemiol. 2009 Jan 15;169(2):219–26. doi: 10.1093/aje/kwn353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petitti DB. Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis. 2. New York: Oxford University Press; 2000. Statistical methods in meta-analysis; pp. 94–118. [Google Scholar]
- Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009 Jan;41(1):77–81. doi: 10.1038/ng.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009 Feb;2(1):73–80. doi: 10.1161/CIRCGENETICS.108.829747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009 Feb;2(1):73–80. doi: 10.1161/CIRCGENETICS.108.829747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simonsick EM, Newman AB, Nevitt MC, Kritchevsky SB, Ferrucci L, Guralnik JM, et al. Measuring higher level physical function in well-functioning older adults: Expanding familiar approaches in the health ABC study. J Gerontol A Biol Sci Med Sci. 2001 Oct;56(10):M644–9. doi: 10.1093/gerona/56.10.m644. [DOI] [PubMed] [Google Scholar]
- Skol AD, Scott LJ, Abecasis GR, Boehnke M. Optimal designs for two-stage genome-wide association studies. Genet Epidemiol. 2007 Nov;31(7):776–88. doi: 10.1002/gepi.20240. [DOI] [PubMed] [Google Scholar]
- Tonjes A, Scholz M, Loeffler M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with pre-diabetic phenotypes: Meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care. 2006 Nov;29(11):2489–97. doi: 10.2337/dc06-0513. [DOI] [PubMed] [Google Scholar]



